Prion genetics: New rules for a new kind of gene

Annual Review of Genetics

Volumn 38, Issue , 2004, Pages 681-707

  Wickner, Reed B ^a   Edskes, Herman K ^a   Ross, Eric D ^a   Pierce, Michael M ^a   Baxa, Ulrich ^a   Brachmann, Andreas ^a   Shewmaker, Frank ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Het s ; PIN ; PSI ; URE3 ; Amyloid; PrP

Indexed keywords

AMYLOID; CHAPERONE; MKS1P PROTEIN; NUCLEIC ACID; PRION PROTEIN; PROTEIN; RAS PROTEIN; RECOMBINANT PROTEIN; SUP35P PROTEIN; UNCLASSIFIED DRUG;

ALLELE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVATION; EPIDEMIOLOGICAL DATA; GENE; GENE IDENTIFICATION; HUMAN; NONHUMAN; PHENOTYPE; PODOSPORA; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; SINC GENE; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS INFECTIVITY; VIRUS STRAIN; VIRUS TRANSMISSION;

AMYLOID; ANIMALS; CRICETINAE; HUMANS; MICE; MODELS, BIOLOGICAL; MOLECULAR CHAPERONES; PHENOTYPE; PODOSPORA; PRION DISEASES; PRIONS; PROTEIN BINDING; SACCHAROMYCES CEREVISIAE; YEASTS;

PODOSPORA;

EID: 10944228369     PISSN: 00664197     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genet.38.072902.092200     Document Type: Review

References (144)

1. 2003. Prions for physicians. Br. Med. Bull. 66:1-316
2. Aguzzi A. 2003. Prions and the immune system: a journey through gut, spleen and nerves. Adv. Immunol. 81:123-71
3. Aguzzi A, Polymenidou M. 2004. Mammalian prion biology, one century of evolving concepts. Cell 116:313-27
4. Aigle M. 1979. Contribution à l ' étude de l'heredité non-chromosomique de Saccharomyces cerevisiae facteur [URE3] etplasmides hybrides. PhD thesis. Univ. Louis Pasteur de Strasbourg, Strasbourg, France. 95 pp.
5. Aigle M, Lacroute F. 1975. Genetical aspects of [URE3], anon-Mendelian, cytoplasmically inherited mutation in y east. Mol. Gen. Genet. 136:327-35
6. Alper T, Cramp WA, Haig DA, Clarke MC. 1967. Does the agent of scrapie replicate without nucleic acid? Nature 214:764-66
7. Bach S, Talarek N, Andrieu T, Vierfond JM, Mettey Y, et al. 2003. Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat. Biotechnol 21:1075-81
8. Balguerie A, Dos Reis S, Ritter C, Chaignepain S, Coulary-Salin B, et al. 2003. Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina. EMBO J. 22:2071-81
9. Baxa U, Speransky V, Steven AC, Wickner RB. 2002. Mechanism of inactivation on prion conversion of the Sacchammyces cerevisiae Ure2 protein. Proc. Natl. Acad. Sci. USA 99:5253-60
10. Baxa U, Taylor KL, Wall JS, Simon MN, Cheng N, et al. 2003. Architecture of Ure2p prion filaments: The N-terminal domain forms a central core fiber. J. Biol. Chem. 278:43717-27
11. Beck T, Hall MN. 1999. The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature 402:689-92
12. Begueret J, Turq B, Clave C. 1994. Vegetative incompatibility in filamentous fungi: het genes begin to talk. Trends Genet. 10:441-46
13. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Landsbury PT, Caughey B. 1995. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375:698-700
14. Bolton DC, McKinley MP, Prusiner SB. 1982. Identification of a protein that purifies with the scrapie prion. Science 218:1309-11
15. Bousset L, Beirhali H, Janin J, Melki R, Morera S. 2001. Structure of the globular region of the prion protein Ure2 from the yeast Saccharomyces cerevisiae. Structure 9:39-46
16. Bousset L, Thomson NH, Radford SE, Melki R. 2002. The yeast prion Ure2p retains its native α-helical conformation upon assembly into protein fibrils in vitro. EMBO J. 21:2903-11
17. Brown P, Gibbs CJ, Rogers-Johnson P, Asher DM, Sulima MP, et al. 1994. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 35:513-29
18. Bruce ME. 2003. TSE strain variation. Br. Med. Bull. 66:99-108
19. Bruce ME, Chree A, McConnell I, Foster J, Pearson G, Fraser H. 1994. Transmission of bovine spongiform encephalopathy and scrapie to mice-strain variation and the species barrier. Philos. Trans. R. Soc. London Ser. B 343:405-11
20. Bruce ME, McConnell I, Fraser H, Dickinson AG. 1991. The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J. Gen. Virol. 72:595-603
21. Bueler H, Aguzzi A, Sailer A, Greiner R-A, Autenried P, et al. 1993. Mice devoid of PrP are resistant to Scrapie. Cell 73:1339-47
22. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, et al. 1992. Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-82
23. +] prion-curing factor. Curr. Genet. 39:62-67
24. Cardenas ME, Cutler NS, Lorenz MC, Di Como CJ, Heitman J. 1999. The TOR signaling cascade regulates gene expression in response to nutrients. Genes Dev. 13:3271-79
25. Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, et al. 1986. Linkagae of prion protein and scrapie incubation time genes. Cell 46:503-11
26. Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, et al. 2002. Role of Escherichia coli Curli operons in directing amyloid fiber formation. Science 295:851-55
27. Chernoff YO, Derkach IL, Inge-Vechtomov SG. 1993. Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae. Curr. Genet. 24:268-70
28. Chernoff YO, Galkin AP, Lewitin E, Chernova TA, Newnam GP, Belenkly SM. 2000. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein. Mol. Micmbiol. 35:865-76
29. +]. Science 268:880-84
30. +] prion. Mol. Cell. Biol. 19:8103-12
31. Chernoff YO, Ono B-I. 1992. Dosage-dependent modifiers of PSI-dependent omnipotent suppression in yeast. In Protein Synthesis and Targeting in Yeast, ed. AJP Brown, MF Tuite, JEG McCarthy, pp. 101-7. Berlin: Springer-Verlag
32. Chernoff YO, Uptain SM, Lindquist S. 2002. Analysis of prion factors in yeast. Methods Enzymol 351:499-538
33. Chesebro B, Race R, Wehrly K, Nishio J, Bloom M, et al. 1985. Identification of scrapie prion protein-specific mRNA in scrapie-infected brain. Nature 315:331-33
34. Cooper TG. 2002. Transmitting the signal of excess nitrogen in Saccharomyces cerevisiae from the Tor proteins to th GATA factors: connecting the dots. FEMS Microbiol. Rev. 26:223-38
35. Coschigano PW, Magasanik B. 1991. The URE2 gene product of Saccharomyces cerevisiae plays an important role in the cellular response to the nitrogen source and has homology to glutathione S-transferases. Mol. Cell. Biol. 11:822-32
36. Coustou V, Deleu C, Saupe S, Begueret J. 1997. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl. Acad. Sci. USA 94:9773-78
37. Coustou V, Deleu C, Saupe SJ, Begueret J. 1999. Mutational analysis of the [Het-s] prion analog of Podospora anserina: A short N-terminal peptide allows prion propagation. Genetics 153:1629-40
38. Coustou-Linares V, Maddelein ML, Begueret J, Saupe SJ. 2001. In vivo aggreg ation of the HET-s prion protein of the fungus Podospora anserina. Mol. Microbiol. 42:1325-35
39. Cox BS. 1965. PSI, a cytoplasmic suppressor of super-suppressor in yeast. Heredity 20:505-21
40. Cox BS. 1971. A recessive lethal super-suppressor mutation in yeast and other PSI phenomena. Heredity 26:211-32
41. +], a novel Sup35-prion variant propagated with non-G1n/Asn oligopeptide repeats in the absence of the chaperone protein Hsp104. Genes Cells 8:603-18
42. Cuille J, Chelle PL. 1936. Pathologie animale. La maladie dite tremblant du mouton est-elle inoculable? C. R. Acad. Sci. 203:1552-54
43. Dalstra HJP, Swart K, Debets AJM, Saupe SJ, Hoekstra RF. 2003. Sexual transmission of the [Het-s] prion leads to meiotic drive in Podospora anserina. Proc. Natl. Acad. Sci. USA 100:6616-21
44. Deleu C, Clave C, Begueret J. 1993. A single amino acid difference is sufficient to elicit vegetative incompatibility in the fungus Podospora anserina. Genetics 135:45-52
45. DePace AH, Santoso A, Hillner P, Weissman JS. 1998. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93:1241-52
46. Derkatch BL, Bradley ME, Hong JY, Liebman SW. 2001. Prions affect the appearance of other prions: the story of [PIN]. Cell 106:171-82
47. +]: a two-prion system in yeast? EMBO J. 19:1942-52
48. +] prion in Saccharomyces cerevisiae. Genetics 147:507-19
49. Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW 1996. Genesis and variability of [PSI] prion factors in Sacchammyces cerevisiae. Genetics 144:1375-86
50. Dickinson AG, Meikle VMH, Fraser H. 1968. Identification of a gene which controls the incubation period of some strains of scrapie in mice. J. Comp. Pathol. 78:293-99
51. Diringer H, Gelderblom H, Hilmert H, Ozel M, Edelbluth C, Kimberlin RH. 1983. Scrapie infectivity, fibrils and low molecular weight protein. Nature 306:476-78
52. Dobson CM. 1999. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24:329-32
53. - mutation which eliminates the [PSI] factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137:659-70
54. Dos Reis S, Coulary-Salin B, Forge V, Lascu I, Begueret J, Saupe SJ. 2002. The HET-s prion protein of the filamentous fungus Podospora anserina aggregates in vitro into amyloid-like fibrils. J. Biol. Chem. 277:5703-6
55. Drillien R, Lacroute F. 1972. Ureido-succinic acid uptake in yeast and some aspects of its regulation. J. Bacteriol. 109:203-8
56. +] of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 97:240-44
57. Edskes HK, Gray VT, Wickner RB. 1999. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc. Natl. Acad. Sci. USA 96:1498-503
58. Edskes HK, Wickner RB. 2000. A protein required for prion generation: [URE3] induction requires the Ras-regulated Mks1 protein. Proc. Natl. Acad. Sci. USA 97:6625-29
59. +] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol. Microbiol. 40:1357-69
60. Frolova L, LeGoff X, Rasmussen HH, Cheperegin S, Drugeon G, et al. 1994. A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor. Nature 372:701-3
61. Gajdusek DC. 1996. Infectious amyloidosis: subacute spongiform encephalopathies as transmissible cerebral amyloidoses. In Fields Virology, ed. BN Fields, DM Knipe, PM Howley, pp. 2851-900. Philadelphia: Raven
62. Gajdusek DC, Gibbs CJ, Alpers M. 1967. Transmission and passage of experimental "kuru" to chimpanzees. Science 155:212-14
63. +], a heritable prion-like factor of S. cerevisiae. Cell 89:811-19
64. Glover JR, Lindquist S. 1998. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94:73-82
65. Griffith JS. 1967. Self-replication and scrapie. Nature 215:1043-44
66. Grimminger V, Richter K, Imhof A, Buchner J, Walter S. 2004. The prion curing agent guanidinium chloride specifically inibits ATP hydrolysis by Hsp104. J. Biol. Chem. 279:7378-83
67. Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S. 1983. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35:849-57
68. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, et al. 1989. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338:342-45
69. Jackson GS, Hosszu LL, Power A, Hill AF, Kenny J, et al. 1999. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283:1935-37
70. Jones EW. 1991. Three proteolytic systems in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 266:7963-66
71. +] priori impaired by factors that regulate Hsp70 substrate binding. Mol. Cell Biol. 24:3928-37
72. +)]. Genetics 163:495-506
73. Jung G, Jones G, Masison DC. 2002. Amino acid residue 184 of yeast Hsp104 chaperone is critical for prion-curing by guanidine, prion propagation, and thermotolerance. Proc. Natl. Acad. Sci. USA 99:9936-41
74. +] as a cellular stress. Genetics 156:559-70
75. Jung G, Masison DC. 2001. Guanidine hydrochloride inhibits Hsp 104 activity in vivo: a possible explanation for its effect in curing yeast prions. Curr. Microbiol. 43:7-10
76. Kellings K, Meyer N, Mirenda C, Prusiner SB, Riesner D. 1992. Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis (RRGE). J. Gen. Microbiol. 73:1025-29
77. Kicka S, Silar P. 2004. PaASK1, a mitogen-activated protein kinase kinase kinase that controls cell degeneration and cell differentiation in Podospora anserina. Genetics 166:1241-52
78. King CY. 2001. Supporting the structural basis of prion strains: induction and identification of [PSI] variants. J. Mol. Biol. 307:1247-60
79. King CY, Diaz-Avalos R. 2004. Protein-only transmission of three yeast prion strains. Nature 428:319-23
80. King C-Y, Tittmann P, Gross H, Gebert R, Aebi M, Wuthrich K. 1997. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc. Natl. Acad. Sci. USA 94:6618-22
81. Kirschner DA, Damas A, Teplow D. 2000. Special issue on amyloid: twist and sheet. J. Struct. Biol. 130:101-383
82. + prion determinant propagation by a mutation of the N terminus of the yeast Sup35 protein. EMBO J. 17:5805-10
83. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, et al. 1994. Cell-free formation of protease-resistant prion protein. Nature 370:471-74
84. Kocisko DA, Priola SA, Raymond GJ, Chesebro B, Landsbury PT, Caughey B. 1995. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc. Natl. Acad. Sci. USA 92:3923-27
85. Kruger K, Grabowski PJ, Zaug AJ, Sands J, Gottschling DE, Cech TR. 1982. Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell 31:147-57
86. Lacroute F. 1971. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J. Bacteriol. 106:519-22
87. Legname G, Baskakov IV, Nguyen H-OB, Reisner D, Cohen FE, et al. 2004. Synthetic mammalian prions. Science 305:673-76
88. Li L, Lindquist S. 2000. Creating a protein-based element of inheritance. Science 287:661-64
89. Liu JJ, Lindquist S. 1999. Oligopeptide-repeat expansions modulate 'protein-only' inheritance in yeast. Nature 400:573-76
90. -] mutations in Saccharomyces cerevisiae. Genet. Res. 37:173-82
91. Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ. 2002. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl. Acad. Sci. USA 99:7402-7
92. Maddelein M-L, Wickner RB. 1999. Two prion-inducing regions of Ure2p are non-overlapping. Mol. Cell. Biol. 19:4516-24
93. Magasanik B, Kaiser CA. 2002. Nitrogen regulation in Saccharomyces cerevisiae. Gene 290:1-18
94. Masison DC, Maddelein M-L, Wickner RB. 1997. The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation. Proc. Natl. Acad. Sci. USA 94:12503-8
95. Masison DC, Wickner RB. 1995. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270:93-95
96. Matsuura A, Anraku Y. 1993. Characterization of the MKS1 gene, a new negative regulator of the ras-cyclic AMP pathway in Saccharomyces cerevisiae. Mol. Gen. Genet. 238:6-16
97. Merz PA, Somerville RA, Wisniewski HM, Iqbal K. 1981. Abnormal fibrils from scrapie infected brain. Acta Neuropathol 54:63-74
98. Moehle CM, Jones EW. 1990. Consequences of growth media, gene copy number and regulatory mutations on the expression of the PRB1 bene of Saccharomyces cerevisiae. Genetics 124:39-55
99. Moehle CM, Tizard R, Lemmon SK, Smart J, Jones EW. 1987. Protease B of the lysosomelike vacuole of the yeast Saccharomyces cerevisiae is homologous to the subtilisin family of serine proteases. Mol. Cell Biol 7:4390-99
100. Moriyama H, Edskes HK, Wickner RB. 2000. [URE3] prion propagation in Saccharomyces cerevisiae: requirement for chaperone Hsp104 and curing by over-expressed chaperone Ydj1p. Mol. Cell. Biol. 20:8916-22
101. Nebes VL, Jones EW. 1991. Activation of the proteinase B precursor of the yeast Saccharomyces cerevisiae by autocatalysis and by an internal sequence. J. Biol. Chem. 266:22851-57
102. Ness F, Ferreira P, Cox BS, Tuite MF. 2002. Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol. Cell. Biol. 22:5593-605
103. Newnam GP, Wegrzyn RD, Lindquist SL, Chernoff YO. 1999. Antagonistic interactions between yeast chaperones Hsp104 and Hsp70 in prion curing. Mol. Cell. Biol. 19:1325-33
104. Oesch B, Westaway D, Walchli M, McKinley MP, Kent SB, et al. 1985. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40:735-46
105. Owen F, Poulter M, Lofthouse R, Collinge J, Crow TJ, et al. 1989. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet1:51-52
106. Parham SN, Resende CG, Tuite MF. 2001. Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions. EMBO J. 20:2111-19
107. Patino MM, Liu J-J, Glover JR, Lindquist S. 1996. Support for the prion hypothesis for inheritance of a pheno-typic trait in yeast. Science 273:622-26
108. +] determinant is mediated by oligomerization of the 5W35-encoded polypeptide chain release factor. EMBO J. 15:3127-34
109. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. 1997. In vitro propagation of the prion-like state of yeast Sup35 protein. Science 277:381-83
110. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, et al. 2002. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA 99:16742-47
111. Podrabsky JE, Carpenter JF, Hand SC. 2001. Survival of water stress in annual fish embryos: dehydration avoidance and egg amyloid fibers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280:R123-31
112. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-44
113. Prusiner SB, ed. 2004. Prion Biology and Diseases. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press. 1050 pp.
114. Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE. 1984. Purification and structural studies of a major scrapie prion protein. Cell 38:127-34
115. Race R, Meade-White K, Raines A, Raymond GJ, Caughey B, Chesebro B. 2002. Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages. J. Infect. Dis. 186:8166-70
116. Resende CG, Outeiro TF, Sands L, Lindquist S, Tuite MF. 2003. Prion protein gene polymorphisms in Saccharomyces cerevisiae. Mol. Microbiol 49:1005-17
117. Rizet G. 1952. Les phénomènes de barrage chez Podospora anserina: analyse génétique des barrages entre les souches s et S. Rev. Cytol. Biol. Veg. 13:51-92
118. Roberts BT, Moriyama H, Wickner RB. 2004. [URE3] prion propagation is abolished by a mutation of the primary cytosolic Hsp70 of budding yeast. Yeast 21:107-17
119. Roberts BT, Wickner RB. 2003. A class of prions that propagate via covalent auto-activation. Genes Dev. 17:2083-87
120. Ross ED, Baxa U, Wickner RB. 2004. Scrambled prion domains form prions and amyloid. Mol. Cell Biol. 24:7206-13
121. Saupe SJ. 2000. Molecular genetics of heterokaryon incompatibility in filamentous ascomycetes. Microbiol. Mol. Biol. Rev. 64:489-502
122. Saupe SJ, Clave C, Begueret J. 2000. Vegetative incompatibility in filamentous fungi: Podospora and Neurospora provide some clues. Curr. Opin. Microbiol. 3:608-12
123. Schlumpberger M, Prusiner SB, Herskowitz I. 2001. Induction of distinct [URE3] yeast prion strains. Mol Cell Biol. 21:7035-46
124. +] and [URE3] prions and curing of [URE3] by Hsp70 protein chaperone Ssalp but not by Ssa2p. Mol. Cell. Biol. 22:3590-98
125. Silar P, Haedens V, Rossingnol M, Lalucque H. 1999. Propagation of a novel cytoplasmic, infectious and deleterious determinant is controlled by translational accuracy in Podospora anserina. Genetics 151:87-95
126. + in yeast by hypertonic media. Proc. Natl Acad. Sci. USA 76:1952-56
127. Somerville RA, Oberthur RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG. 2002. Characterization of thermodynamic diversity between transmissible spongiform encephalopathy agent strains and its theoretical implications. J. Biol. Chem. 277:11084-89
128. Sondheimer N, Lindquist S. 2000. Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell 5:163-72
129. Speransky V, Taylor KL, Edskes HK, Wickner RB, Steven A. 2001. Prion filament networks in [URE3] cells of Saccharomyces cerevisiae. J. Cell. Biol. 153:1327-35
130. Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznyakovski AI, et al. 1995. The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J. 14:4365-73
131. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. 2004. Conformational variations in an infectious protein determine prion strain differences. Nature 428:323-28
132. Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB. 1999. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283:1339-43
133. +] in the yeast Saccharomyces cerevisiae. Genetics 137:671-76
134. Tuite MF, Cox BS. 2003. Propagation of yeast prions. Nat. Rev. Mol. Cell. Biol. 4:878-90
135. -] in Saccharomyces cerevisiae. Genetics 98:691-711
136. Turcq B, Denayrolles M, Begueret J. 1990. Isolation of two alleles incompatibility genes J and S of the fungus Podospora anserina. Curr. Genet. 17:297-303
137. Tycko R. 2003. Insights into the amyloid folding problem from solid-state NMR. Biochemistry 42:3151-59
138. Umland TC, Taylor KL, Rhee S, Wickner RB, Davies DR. 2001. The crystal structure of the nitrogen catabolite regulatory fragment of the yeast prion protein Ure2p. Proc. Natl. Acad. Sci. USA 98:1459-64
139. Wadsworth JDF, Hill AF, Beck JA, Collinge J. 2003. Molecular and clinical classification of human prion disease. Br. Med. Bull. 66:241-54
140. Wickner RB. 1994. Evidence for a prion analog in S. cerevisiae: the [URE3] non-Mendelian genetic element as an altered URE2 protein. Science 264:566-69
141. Wickner RB. 1996. Prions and RNA viruses of Saccharomyces cerevisiae. Annu. Rev. Genet. 30:109-35
142. Wickner RB. 2001. Viruses of yeasts, fungi and parasitic microorganisms. In Fields Virology, ed. DM Knipe, PM Howley, pp. 629-58. Philadelphia: Lippincott, Williams & Wilkins
143. Wickner RB, Liebman SW, Saupe S. 2004. Prions of yeast and filamentous fungi. See Ref. 109, pp. 305-72
144. Zubenko GS, Park FJ, Jones EW. 1982. Genetic properties of mutations at the PEP4 locus in Saccharomyces cerevisiae. Genetics 102:679-90